ÂÜÀòÂÒÂ×

James Brennan is a Senior Scientist with extensive experience in developing cell-based assays for AAV-based gene therapies. Prior to their current role, James held various positions in analytical development and research, contributing to programs focused on DNA-based therapies for different medical conditions. James has a Ph.D in Biomedical Engineering from the University of Rochester, where James conducted research on fibronectin matrix mimetics. James also has a Master's degree in Biomedical Engineering and a Bachelor's degree in Bioengineering and Biomedical Engineering.